Wall Street analysts expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce earnings per share (EPS) of $0.63 for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for U.S. Physical Therapy’s earnings. The lowest EPS estimate is $0.62 and the highest is $0.64. U.S. Physical Therapy reported earnings per share of $0.49 during the same quarter last year, which suggests a positive year-over-year growth rate of 28.6%. The business is expected to report its next quarterly earnings results before the market opens on Thursday, March 7th.
According to Zacks, analysts expect that U.S. Physical Therapy will report full-year earnings of $2.55 per share for the current year, with EPS estimates ranging from $2.53 to $2.57. For the next fiscal year, analysts forecast that the company will report earnings of $2.76 per share, with EPS estimates ranging from $2.65 to $2.90. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that cover U.S. Physical Therapy.
A number of equities research analysts recently weighed in on the company. Zacks Investment Research cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Saturday, February 9th. Cantor Fitzgerald increased their price target on U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Finally, TheStreet cut U.S. Physical Therapy from a “b” rating to a “c+” rating in a research note on Friday, November 2nd. Five analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company’s stock. U.S. Physical Therapy has a consensus rating of “Hold” and a consensus target price of $113.67.
USPH traded up $4.25 during trading hours on Friday, reaching $112.08. The company’s stock had a trading volume of 227,926 shares, compared to its average volume of 86,670. U.S. Physical Therapy has a 52 week low of $74.75 and a 52 week high of $129.65. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt-to-equity ratio of 0.26. The stock has a market cap of $1.42 billion, a PE ratio of 53.88, a price-to-earnings-growth ratio of 3.44 and a beta of 1.14.
In other news, Director Harry S. Chapman acquired 1,200 shares of the firm’s stock in a transaction on Tuesday, December 11th. The shares were purchased at an average cost of $110.69 per share, with a total value of $132,828.00. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Regg E. Swanson acquired 500 shares of the firm’s stock in a transaction on Wednesday, December 26th. The stock was purchased at an average cost of $101.17 per share, for a total transaction of $50,585.00. The disclosure for this purchase can be found here. Corporate insiders own 2.50% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Resources Investment Advisors Inc. acquired a new stake in shares of U.S. Physical Therapy during the 4th quarter worth $42,000. Vestor Capital LLC acquired a new stake in shares of U.S. Physical Therapy during the 4th quarter worth $51,000. We Are One Seven LLC acquired a new stake in shares of U.S. Physical Therapy during the 4th quarter worth $133,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of U.S. Physical Therapy during the 3rd quarter worth $190,000. Finally, Advisor Group Inc. grew its holdings in shares of U.S. Physical Therapy by 14.5% during the 4th quarter. Advisor Group Inc. now owns 1,871 shares of the company’s stock worth $191,000 after purchasing an additional 237 shares in the last quarter. 99.45% of the stock is currently owned by hedge funds and other institutional investors.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading: What is a Stop Order?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.